| Combination of | |
|---|---|
| Cinnarizine | Antihistamine and calcium channel blocker |
| Dimenhydrinate | Antihistamine and antiemetic |
| Clinical data | |
| Trade names | Cizigo, Cizinate, Cizere |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| UNII | |
Cinnarizine/dimenhydrinate, sold under the brand name Cizinate among others is a fixed-dose combination medication for the treatment of vertigo in adults.[1] It contains cinnarizine and dimenhydrinate.[1] It is taken by mouth.[1]
It was approved for medical use in Australia in December 2018.[1]